XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIT (Unaudited) - USD ($)
Total
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance, shares at Dec. 31, 2019   1,323,000 20,570,000      
Balance, amount at Dec. 31, 2019 $ (154,372,000) $ 1,000 $ 21,000 $ 86,852,000 $ (237,421,000) $ (3,825,000)
Stock-based compensation 310,000 0 $ 0 310,000 0 0
Issuance and exercise of warrants, shares     113,000      
Issuance and exercise of warrants, amount 93,000 0 $ 0 93,000 0 0
Foreign currency translation loss (668,000) 0 0 0 0 (668,000)
Net loss (12,052,000) $ 0 $ 0 0 (12,052,000) 0
Balance, shares at Mar. 31, 2020   1,323,000 20,683,000      
Balance, amount at Mar. 31, 2020 (166,689,000) $ 1,000 $ 21,000 87,255,000 (249,473,000) (4,493,000)
Balance, shares at Dec. 31, 2019   1,323,000 20,570,000      
Balance, amount at Dec. 31, 2019 (154,372,000) $ 1,000 $ 21,000 86,852,000 (237,421,000) (3,825,000)
Stock-based compensation 826,000          
Net loss (22,077,000)          
Foreign currency translation gain (381,000)          
Balance, shares at Sep. 30, 2020   1,323,000 21,027,000      
Balance, amount at Sep. 30, 2020 (175,563,000) $ 1,000 $ 21,000 88,119,000 (259,498,000) (4,206,000)
Balance, shares at Mar. 31, 2020   1,323,000 20,683,000      
Balance, amount at Mar. 31, 2020 (166,689,000) $ 1,000 $ 21,000 87,255,000 (249,473,000) (4,493,000)
Stock-based compensation 325,000 0 0 325,000 0 0
Issuance and exercise of warrants, amount 0 0 0 0 0 0
Foreign currency translation loss (27,000) 0 0 0 0 (27,000)
Net income 2,192,000 $ 0 $ 0 0 2,192,000 0
Balance, shares at Jun. 30, 2020   1,323,000 20,683,000      
Balance, amount at Jun. 30, 2020 (164,199,000) $ 1,000 $ 21,000 87,580,000 (247,281,000) (4,520,000)
Stock-based compensation 191,000 0 $ 0 191,000 0 0
Issuance and exercise of warrants, shares     112,000      
Issuance and exercise of warrants, amount 88,000 0 $ 0 88,000 0 0
Net loss (12,217,000) 0 $ 0 0 (12,217,000) 0
Stock options exercised, shares     232,000      
Stock options exercised, amount 260,000 0 $ 0 260,000 0 0
Foreign currency translation gain 314,000 $ 0 $ 0 0 0 314,000
Balance, shares at Sep. 30, 2020   1,323,000 21,027,000      
Balance, amount at Sep. 30, 2020 (175,563,000) $ 1,000 $ 21,000 88,119,000 (259,498,000) (4,206,000)
Balance, shares at Dec. 31, 2020   1,323,000 22,830,000      
Balance, amount at Dec. 31, 2020 (184,744,000) $ 1,000 $ 23,000 93,426,000 (274,080,000) (4,114,000)
Stock-based compensation 835,000 0 $ 0 835,000 0 0
Issuance and exercise of warrants, shares     113,000      
Issuance and exercise of warrants, amount 281,000 0 $ 0 281,000 0 0
Foreign currency translation loss (25,000) 0 0 0 0 (25,000)
Net loss (18,112,000) 0 $ 0 0 (18,112,000) 0
Stock options exercised, shares     1,226,000      
Stock options exercised, amount 1,003,000 0 $ 1,000 1,002,000 0 0
Issuance of common stock, shares     5,682,000      
Issuance of common stock, amount 62,395,000 $ 0 $ 6,000 62,389,000 0 0
Balance, shares at Mar. 31, 2021   1,323,000 29,851,000      
Balance, amount at Mar. 31, 2021 (138,367,000) $ 1,000 $ 30,000 157,933,000 (292,192,000) (4,139,000)
Balance, shares at Dec. 31, 2020   1,323,000 22,830,000      
Balance, amount at Dec. 31, 2020 (184,744,000) $ 1,000 $ 23,000 93,426,000 (274,080,000) (4,114,000)
Stock-based compensation 1,400,000          
Net loss $ (46,266,000)          
Stock options exercised, shares 0          
Foreign currency translation gain $ (187,000)          
Balance, shares at Sep. 30, 2021   1,285,000 32,564,000      
Balance, amount at Sep. 30, 2021 (132,093,000) $ 1,000 $ 33,000 192,520,000 (320,346,000) (4,301,000)
Balance, shares at Mar. 31, 2021   1,323,000 29,851,000      
Balance, amount at Mar. 31, 2021 (138,367,000) $ 1,000 $ 30,000 157,933,000 (292,192,000) (4,139,000)
Stock-based compensation 281,000 0 0 281,000 0 0
Foreign currency translation loss (184,000) 0 0 0 0 (184,000)
Net loss (10,557,000) 0 $ 0 0 (10,557,000) 0
Stock options exercised, shares     745,000      
Stock options exercised, amount 29,000 0 $ 1,000 28,000 0 0
Issuance of common stock, shares     976,000      
Issuance of common stock, amount 24,774,000 $ 0 $ 1,000 24,773,000 0 0
Balance, shares at Jun. 30, 2021   1,323,000 31,572,000      
Balance, amount at Jun. 30, 2021 (124,024,000) $ 1,000 $ 32,000 183,015,000 (302,749,000) (4,323,000)
Stock-based compensation 285,000   $ 0 285,000 0 0
Issuance and exercise of warrants, shares     113,000      
Issuance and exercise of warrants, amount 1,265,000   $ 0 1,265,000 0 0
Net loss (17,597,000)     0 (17,597,000) 0
Stock options exercised, shares     299,000      
Stock options exercised, amount 72,000   $ 0 72,000 0 0
Foreign currency translation gain 22,000     0 0 22,000
Issuance of common stock, shares     576,000      
Issuance of common stock, amount 7,884,000   $ 1,000 7,883,000 0 0
Series B conversion to common stock, shares   (38) 4      
Sereis B conversion to common stock, amount 0 $ 0 $ 0 0 0 0
Balance, shares at Sep. 30, 2021   1,285,000 32,564,000      
Balance, amount at Sep. 30, 2021 $ (132,093,000) $ 1,000 $ 33,000 $ 192,520,000 $ (320,346,000) $ (4,301,000)